相似文献
1
Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.
J Zhejiang Univ Sci B. 2010 Feb;11(2):144-50. doi: 10.1631/jzus.B0900266.
2
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.
Mol Oncol. 2013 Jun;7(3):611-24. doi: 10.1016/j.molonc.2013.02.001. Epub 2013 Feb 26.
3
Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.
J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):20-4. doi: 10.1016/j.jsbmb.2008.07.004. Epub 2008 Jul 25.
4
Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.
J Clin Oncol. 2009 Jul 20;27(21):3423-9. doi: 10.1200/JCO.2008.17.2254. Epub 2009 Jun 1.
5
Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancer.
PLoS One. 2014 Aug 15;9(8):e104459. doi: 10.1371/journal.pone.0104459. eCollection 2014.
6
ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.
Anticancer Res. 2008 Jan-Feb;28(1B):479-83.
7
let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.
Mol Med. 2011;17(11-12):1233-41. doi: 10.2119/molmed.2010.00225. Epub 2011 Jul 27.
8
Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Cell Biol Toxicol. 2017 Apr;33(2):183-195. doi: 10.1007/s10565-016-9365-6. Epub 2016 Nov 11.
9
ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast.
J Clin Pathol. 2011 Jan;64(1):54-7. doi: 10.1136/jcp.2010.082776. Epub 2010 Nov 2.
10
A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9063-8. doi: 10.1073/pnas.0603339103. Epub 2006 Jun 5.
引用本文的文献
1
ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
Int J Mol Sci. 2021 Jul 16;22(14):7603. doi: 10.3390/ijms22147603.
2
The Role of ERα36 in Development and Tumor Malignancy.
Int J Mol Sci. 2020 Jun 9;21(11):4116. doi: 10.3390/ijms21114116.
3
Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics.
Pituitary. 2020 Jun;23(3):232-245. doi: 10.1007/s11102-020-01029-z.
4
Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells.
Cancer Sci. 2019 Jan;110(1):221-234. doi: 10.1111/cas.13868.
5
Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36.
Oncol Rep. 2018 Jun;39(6):2604-2612. doi: 10.3892/or.2018.6350. Epub 2018 Apr 2.
6
Estrogen receptor profiling and activity in cardiac myocytes.
Mol Cell Endocrinol. 2016 Aug 15;431:62-70. doi: 10.1016/j.mce.2016.05.004. Epub 2016 May 7.
7
ER-α36: a novel biomarker and potential therapeutic target in breast cancer.
Onco Targets Ther. 2014 Aug 30;7:1525-33. doi: 10.2147/OTT.S65345. eCollection 2014.
8
The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors.
J Transl Med. 2014 Jan 21;12:16. doi: 10.1186/1479-5876-12-16.
本文引用的文献
1
Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.
J Clin Oncol. 2009 Jul 20;27(21):3423-9. doi: 10.1200/JCO.2008.17.2254. Epub 2009 Jun 1.
2
Cancer statistics, 2009.
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
3
Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.
J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):20-4. doi: 10.1016/j.jsbmb.2008.07.004. Epub 2008 Jul 25.
4
ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.
Anticancer Res. 2008 Jan-Feb;28(1B):479-83.
5
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Breast Cancer Res. 2007;9(1):R6. doi: 10.1186/bcr1639.
6
Observations on the presence of E domain variants of estrogen receptor-alpha in the breast tumors.
J Surg Oncol. 2006 Sep 15;94(4):332-7. doi: 10.1002/jso.20588.
7
A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9063-8. doi: 10.1073/pnas.0603339103. Epub 2006 Jun 5.
8
Quantitative profile of estrogen receptor variants/isoforms in Taiwanese women with breast cancer.
Eur J Surg Oncol. 2006 Jun;32(5):492-7. doi: 10.1016/j.ejso.2006.02.010. Epub 2006 Mar 23.
9
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.
Biochem Biophys Res Commun. 2005 Nov 4;336(4):1023-7. doi: 10.1016/j.bbrc.2005.08.226.
10
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.
Ann Oncol. 2005 Oct;16(10):1569-83. doi: 10.1093/annonc/mdi326. Epub 2005 Sep 7.
Zotero 插件